NEOGEN CHEMICALS LIMITED (NEOGEN) financials

NEOGEN CHEMICALS LIMITED (NEOGEN) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries.[1]

Market Cap: ₹7,465Cr.
Current Price: ₹2,485
Stock P/E: 143
ROE: 5.51%
ROCE: 9.93%
Book Value: ₹324
Dividend Yield: 0.04%
52W High / Low: ₹2,785/967

In Jun 2026, NEOGEN CHEMICALS LIMITED (NEOGEN) reported sales ₹252 Cr and net profit ₹19 Cr.

Annual TTM: sales ₹923 Cr, net profit ₹52 Cr.

Shareholding: Promoters 48.31% (Sep 2026), FIIs 4.51% (Sep 2026), DIIs 23.43% (Sep 2026), Public 23.75% (Sep 2026), No. of Shareholders 68,410% (Sep 2026).

NEOGEN quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	193	200	204	185	207	216	249	252
Expenses	157	163	163	150	172	179	203	204
Operating Profit	36	38	41	35	35	36	45	48
OPM %	19%	19%	20%	19%	17%	17%	18%	19%
Other Income	2	2	-11	3	4	4	4	8
Interest	12	13	16	14	21	23	23	23
Depreciation	7	7	6	5	6	6	6	7
Profit before tax	20	20	8	19	12	12	20	26
Tax %	25%	28%	33%	25%	24%	26%	26%	26%
Net Profit	15	14	5	14	9	9	15	19
EPS in Rs	5.63	5.46	1.97	5.39	3.53	3.32	5.56	7.10
Raw PDF	—	—	—	—	—	—	—	—

NEOGEN profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	306	336	487	686	701	774	855	923
Expenses	248	272	401	575	585	627	704	758
Operating Profit	58	64	87	112	116	147	151	165
OPM %	19%	19%	18%	16%	17%	19%	18%	18%
Other Income	0	1	1	5	8	-4	16	20
Interest	12	14	19	29	42	51	80	90
Depreciation	5	7	12	16	23	26	24	25
Profit before tax	41	44	57	71	59	66	63	70
Tax %	30%	29%	22%	30%	31%	27%	26%	—
Net Profit	29	31	45	50	41	48	47	52
EPS in Rs	12.33	13.47	17.93	20.07	15.59	18.35	17.80	19.51
Dividend Payout %	16%	17%	15%	15%	13%	5%	11%	—

NEOGEN balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	20	23	23	25	25	26	26	26
Reserves	50	133	160	414	458	740	782	827
Borrowings	120	137	222	229	370	409	474	736
Other Liabilities	56	61	87	131	202	230	338	586
Total Liabilities	247	355	492	800	1,054	1,405	1,621	2,176
Fixed Assets	83	111	127	285	347	361	228	294
CWIP	0	3	115	11	36	56	28	161
Investments	0	0	0	81	77	5	193	307
Other Assets	163	242	250	423	594	983	1,173	1,413
Total Assets	247	355	492	800	1,054	1,405	1,621	2,176

NEOGEN cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-4	-34	83	1	-30	-134	199	-99
Cash from Investing Activity	-20	-29	-134	-146	-94	-129	-188	-35
Cash from Financing Activity	24	62	51	188	100	226	-12	137
Net Cash Flow	0	-1	-0	44	-25	-37	-2	3
Free Cash Flow	-24	-63	-52	-65	-134	-207	167	11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	4%	-37%	146%	13%	-17%	-107%	144%	-53%

NEOGEN shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	51.22%	51.22%	51.22%	51.22%	51.22%	51.22%	53.00%	48.31%
FIIs	7.73%	7.79%	7.35%	5.15%	4.57%	4.46%	4.11%	4.51%
DIIs	22.52%	22.75%	22.96%	25.22%	21.99%	22.65%	19.60%	23.43%
Public	18.51%	18.22%	18.45%	18.40%	22.21%	21.67%	23.27%	23.75%
No. of Shareholders	47,651	46,104	46,321	45,710	47,884	54,332	61,988	68,410

NEOGEN key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	93	90	85	82	94	147	94	152
Inventory Days	188	257	211	258	275	353	265	425
Days Payable	111	71	122	131	147	134	220	325
Cash Conversion Cycle	169	276	174	209	223	366	138	252
Working Capital Days	63	96	67	111	80	190	169	110
ROCE %	26%	22%	17%	14%	13%	10%	11%	10%

NEOGENUpdated 19 Oct 2026, 5:51

Neogen Chemicals Limited

NEOGENUpdated 19 Oct 2026, 5:51

Market Cap

₹7,465Cr.

Current Price

₹2,485

High / Low

₹2,785/967

Stock P/E

143

ROE5.51%

ROCE9.93%

Book Value₹324

Face Value₹10.0

Dividend Yield0.04%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	170	11	141	2	5	16	28	11	4.58
Sep 2023	168	11	142	2	5	12	26	9	3.66
Dec 2023	164	11	143	2	6	7	69	2	0.85
Mar 2024	210	10	172	3	6	25	24	19	7.3
Jun 2024	176	10	145	3	6	19	26	14	5.28
Sep 2024	193	12	157	2	7	20	25	15	5.63
Dec 2024	200	13	163	2	7	20	28	14	5.46
Mar 2025	204	16	163	-11	6	8	33	5	1.97
Jun 2025	185	14	150	3	5	19	25	14	5.39
Sep 2025	207	21	172	4	6	12	24	9	3.53
Dec 2025	216	23	179	4	6	12	26	9	3.32
Mar 2026	249	23	203	4	6	20	26	15	5.56
Jun 2026	252	23	204	8	7	26	26	19	7.1

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	84	5	71	1	1	8	37	5	2.54
Mar 2016	100	5	86	0	1	8	39	5	2.59
Mar 2017	110	8	90	0	1	12	33	8	3.88
Mar 2018	161	10	132	1	2	18	39	11	5.34
Mar 2019	239	12	196	1	3	29	28	21	10.48
Mar 2020	306	12	248	0	5	41	30	29	12.33
Mar 2021	336	14	272	1	7	44	29	31	13.47
Mar 2022	487	19	401	1	12	57	22	45	17.93
Mar 2023	686	29	575	5	16	71	30	50	20.07
Mar 2024	701	42	585	8	23	59	31	41	15.59
Mar 2025	774	51	627	-4	26	66	27	48	18.35
Mar 2026	855	80	704	16	24	63	26	47	17.8
TTM	923	90	758	20	25	70	—	52	19.51

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	48.31%
FIIs	4.51%
DIIs	23.43%
Public	23.75%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	56.89%	4.51%	22.85%	15.75%
Mar 2024	56.89%	4.56%	22.14%	16.42%
Jun 2024	56.89%	4.65%	22.54%	15.93%
Sep 2024	51.22%	8.17%	22.48%	18.12%
Dec 2024	51.22%	7.73%	22.52%	18.51%
Mar 2025	51.22%	7.79%	22.75%	18.22%
Jun 2025	51.22%	7.35%	22.96%	18.45%
Sep 2025	51.22%	5.15%	25.22%	18.4%
Dec 2025	51.22%	4.57%	21.99%	22.21%
Mar 2026	51.22%	4.46%	22.65%	21.67%
Jun 2026	53%	4.11%	19.6%	23.27%
Sep 2026	48.31%	4.51%	23.43%	23.75%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	4	19	24	21	69	13	0	0	55	69
Mar 2016	20	8	26	27	80	17	1	0	62	80
Mar 2017	20	22	69	41	152	56	1	0	94	152
Mar 2018	20	31	82	48	181	67	1	0	112	181
Mar 2019	20	50	120	56	247	83	0	0	163	247
Mar 2020	23	133	137	61	355	111	3	0	242	355
Mar 2021	23	160	222	87	492	127	115	0	250	492
Mar 2022	25	414	229	131	800	285	11	81	423	800
Mar 2023	25	458	370	202	1054	347	36	77	594	1054
Mar 2024	26	740	409	230	1405	361	56	5	983	1405
Mar 2025	26	782	474	338	1621	228	28	193	1173	1621
Mar 2026	26	827	736	586	2176	294	161	307	1413	2176

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	9	-2	-6	1
Mar 2016	9	-4	-4	0
Mar 2017	0	-33	33	1
Mar 2018	12	-13	0	-1
Mar 2019	-4	-20	24	0
Mar 2020	-34	-29	62	-1
Mar 2021	83	-134	51	0
Mar 2022	1	-146	188	44
Mar 2023	-30	-94	100	-25
Mar 2024	-134	-129	226	-37
Mar 2025	199	-188	-12	-2
Mar 2026	-99	-35	137	3

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	78	58	107	94	93	90	85	82	94	147	94	152
Inventory Days	178	190	228	192	188	257	211	258	275	353	265	425
Days Payable	120	130	177	141	111	71	122	131	147	134	220	325
Cash Conversion Cycle	136	117	158	145	169	276	174	209	223	366	138	252
Working Capital Days	140	126	67	49	63	96	67	111	80	190	169	110
ROCE %	27%	26%	23%	23%	26%	22%	17%	14%	13%	10%	11%	10%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of NEOGEN CHEMICALS LIMITED (NEOGEN)?

The reported market capitalisation for NEOGEN CHEMICALS LIMITED (NEOGEN) is ₹7,465Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of NEOGEN?

The current price shown for NEOGEN CHEMICALS LIMITED (NEOGEN) on Fincrux is ₹2,485 with a 52-week high/low of ₹2,785/967.

What is the P/E ratio of NEOGEN CHEMICALS LIMITED (NEOGEN)?

The stock P/E for NEOGEN CHEMICALS LIMITED (NEOGEN) is 143 on Fincrux, with ROE at 5.51% and ROCE at 9.93%.

What were NEOGEN latest quarterly results?

For Jun 2026, NEOGEN CHEMICALS LIMITED (NEOGEN) reported sales ₹252 Cr and net profit ₹19 Cr (figures in ₹ crore unless noted).

What are NEOGEN annual sales and net profit?

For TTM, NEOGEN CHEMICALS LIMITED (NEOGEN) shows sales of ₹923 Cr and net profit of ₹52 Cr on the Fincrux profit & loss statement.

Who owns NEOGEN CHEMICALS LIMITED (NEOGEN)?

Latest shareholding for NEOGEN CHEMICALS LIMITED (NEOGEN) on Fincrux: Promoters 48.31% (Sep 2026), FIIs 4.51% (Sep 2026), DIIs 23.43% (Sep 2026), Public 23.75% (Sep 2026), No. of Shareholders 68,410% (Sep 2026).

Where can I find NEOGEN CHEMICALS LIMITED (NEOGEN) financials?

NEOGEN CHEMICALS LIMITED (NEOGEN) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show NEOGEN balance sheet and cash flow?

Yes. The NEOGEN CHEMICALS LIMITED (NEOGEN) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 5:51